Clinical trial · Observational
"Xijiang Project" Screening Cohort for NPC
Establishment of "Xijiang Project" Million-Person Screening Cohort for Nasopharyngeal Carcinoma
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to establish a comprehensive and integrated nasopharyngeal carcinoma screening cohort, which includes an epidemiological information database containing basic information, gender, age, ethnic and family history, dietary and lifestyle habits, and geographical environmental factors; a biobank of blood, tissue fluid, swabs, etc., for Epstein-Barr virus, tumors, and genetics; a clinical examination database including nasopharyngoscopy, imaging, pathology, and other examinations; and databases of Epstein-Barr virus and human genetic sequencing, etc.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Nasopharyngeal Carcinoma (NPC) | Nasopharyngeal Carcinoma | ONTOLOGY_EXACT | 0.85 |
| Screening | — | UNRESOLVED | — |
Interventions
Interventions (5)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Clinical examinations for high-risk participants | Other | — | UNRESOLVED |
| EBV and human genetic sequencing | Other | — | UNRESOLVED |
| EBV antibodies test | Diagnostic Test | — | UNRESOLVED |
| EBV DNA test | Diagnostic Test | — | UNRESOLVED |
| epidemiological information survey | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Screening cohort of nasopharyngeal carcinoma
- description
- Population participating in nasopharyngeal carcinoma screening, aged between 30 and 69 years old.
- interventionNames
- Diagnostic Test: EBV antibodies test
- Diagnostic Test: EBV DNA test
- Other: epidemiological information survey
- Other: Clinical examinations for high-risk participants
- Other: EBV and human genetic sequencing
Primary outcomes (1)
- measure
- A data platform for an NPC screening cohort
- timeFrame
- At screening, 3 years and 10 years thereafter
- description
- A data platform, including an NPC epidemiological information database based on the gender, age, ethnicity, dietary and lifestyle habits, and geographical environmental factors, a biobank based on various samples and screening test results, and a clinical examination database based on nasopharyngoscopy, head and neck MRI, and a database for EB virus and human genetic sequencing information.
Secondary outcomes (3)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 30 Years
- Maximum age
- 69 Years
Show eligibility criteria text
Inclusion Criteria: * Residents with a definite native place; * Aged 30 and 69 years at screening; * Capable of long-term cooperation with screening and follow-up. Exclusion Criteria: * Known severe cardiovascular, liver or kidney disease, or neuropsychiatric disorders; * History of previous malignant tumors; * Severe autoimmune diseases or immunodeficiency; * Females with a positive pregnancy test at screening; * Inability to cooperate with the study due to psychological, social, family, and geographical reasons.
References
Publications (0)
Data not yet available